Towards a universal understanding of post COVID-19 condition
Bull World Health Organ
.
2021 Dec 1;99(12):901-903.
doi: 10.2471/BLT.21.286249.
Epub 2021 Oct 5.
Authors
Janet V Diaz
1
,
Margaret Herridge
2
,
Silvia Bertagnolio
3
,
Hannah E Davis
4
,
Tarun Dua
5
,
Charu Kaushic
6
,
John C Marshall
7
,
Maria Del Rosario Pérez
1
,
Nathalie Strub-Wourgaft
8
,
Joan B Soriano
1
Affiliations
1
Clinical Management Team, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
2
Department of Medicine, Interdepartmental Division of Critical Care, University of Toronto, Toronto, Canada.
3
Department of Control, Surveillance and Prevention of Antimicrobial Resistance, World Health Organization, Geneva, Switzerland.
4
Patient-Led Research Collaborative, United States of America.
5
Brain Health Unit, World Health Organization, Geneva, Switzerland.
6
CIHR Institute of Infection and Immunity, McMaster University, Hamilton, Canada.
7
Departments of Surgery and Critical Care Medicine, St Michael's Hospital, Toronto, Canada.
8
Drugs for Neglected Diseases initiative, Geneva, Switzerland.
PMID:
34866686
PMCID:
PMC8640686
DOI:
10.2471/BLT.21.286249
No abstract available
MeSH terms
COVID-19*
Humans
SARS-CoV-2
Grants and funding
001/WHO_/World Health Organization/International